Last reviewed: July 10, 2026
Last updated: July 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide and other GLP-1 medications have transformed weight loss and metabolic health for millions, but surgery requires special planning. The FDA and surgical societies recommend pausing GLP-1 therapy at least one to two weeks before elective procedures to reduce risks of nausea, vomiting, and aspiration during anesthesia.
Why Surgeons Ask You to Stop Semaglutide Before Surgery
Semaglutide slows stomach emptying and reduces appetite by activating GLP-1 receptors in the brain and gastrointestinal tract. During surgery, this delayed gastric transit means food and liquid stay in your stomach longer than normal, even if you've fasted. When anesthesia is administered, the risk of aspiration—where stomach contents enter the airway—increases significantly, potentially causing serious lung complications.
Nausea and vomiting are also more common in patients taking GLP-1 agonists at the time of surgery. These symptoms not only increase discomfort during recovery but can complicate anesthesia monitoring and post-operative care. Surgical teams prioritize airway safety, which is why pre-operative GLP-1 pausing is now standard guidance across major health systems.
How Long to Pause GLP-1 Therapy Before Elective Surgery
Most surgical guidelines recommend discontinuing semaglutide, tirzepatide, and other GLP-1 medications one to two weeks before elective procedures. The exact timing depends on your injection frequency and the type of surgery. For weekly injections like semaglutide, stopping one week before surgery typically allows the medication to clear from your system to a safer level, though traces may remain longer.
Your surgical team and prescribing provider should coordinate on the specific pause timeline. Emergency surgeries may not allow for a full pause period, in which case your anesthesiologist will adjust their approach accordingly. After surgery, your healthcare provider will advise when it is safe to resume semaglutide therapy, usually after you have recovered enough to tolerate oral intake without nausea.
Coordinating GLP-1 Treatment With Your Surgical Team
If you are taking semaglutide or another GLP-1 medication, inform both your surgeon and anesthesiologist at your pre-operative visit. Provide them with the specific medication, dose frequency, and last injection date. This allows them to assess your individual risk factors and adjust anesthetic protocols if needed, such as using different anti-nausea medications or monitoring techniques.
PlexusDx recommends keeping a record of your treatment timeline and sharing it with all care providers involved in your surgery. Communication between your weight loss therapy provider and surgical team ensures smooth coordination, reduces unexpected complications, and helps you return to your treatment plan safely after recovery.
Resuming Semaglutide Safely After Your Procedure
Restarting semaglutide after surgery should be guided by your healthcare provider and depends on your recovery progress. Most patients can resume GLP-1 therapy within one to three weeks after surgery, once they are eating normally and managing post-operative pain. Starting at a lower dose or microdose may reduce nausea risk during early recovery when your system is still healing.
PlexusDx's Microdose GLP-1 Protocol, available at $129 per month, offers a gentle re-entry option for patients resuming therapy after surgery or those new to GLP-1 treatment. Discuss your surgical history and recovery timeline with your PlexusDx provider to determine the best dose and timing for your restart, ensuring continuity of your weight loss and metabolic health goals.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I need to stop semaglutide if I'm having an emergency surgery?
Emergency surgeries may not allow time for a full GLP-1 pause. Inform your surgical and anesthesia team immediately that you take semaglutide so they can modify their safety protocols. Your anesthesiologist will use specialized techniques to manage the increased aspiration risk.
How does semaglutide increase aspiration risk during surgery?
Semaglutide slows gastric emptying, meaning food and liquid remain in your stomach longer than normal. During anesthesia, your protective reflexes are suppressed, so stomach contents can more easily enter your airway. Pausing GLP-1 therapy allows your stomach to return to normal motility before surgery.
Can I get semaglutide injections at PlexusDx without insurance or a membership fee?
Yes. PlexusDx compounded semaglutide injections start at $189/mo (or $149/mo on the 6-month plan) and are available to all 50 states with no insurance required or membership fees. HSA and FSA accounts are eligible for payment.
Will I gain weight back if I pause semaglutide for surgery?
Most patients do not regain significant weight during a one to two week pause, especially if surgery recovery involves dietary restrictions anyway. Resume your semaglutide as directed by your provider once you are medically cleared, and discuss any weight-related concerns at your recovery follow-up.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 pathways and 49 peptides, including GLP1R rs6923761 and MC4R rs17782313 variants that influence GLP-1 response. This genetic insight helps your provider optimize your post-surgical resume dose for better outcomes.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Mounjaro: How It Works in the Body for Weight Management and Metabolic Health
Can I Change the Day I Inject Mounjaro?